Shanwaishan announced that in the third quarter of 2026, it achieved operating income of 273 million yuan, an increase of 20.29%; net profit attributable to shareholders of listed companies was 64,263,500 yuan, an increase of 29.96% year on year; after deducting non-net profit of 587.95 million yuan, an increase of 35.57% year on year. The first three quarters of 2026 achieved operating income of 737 million yuan, an increase of 26.11%; net profit attributable to shareholders of listed companies was 159 million yuan, an increase of 51.82% year on year; after deducting non-net profit of 144 million yuan, an increase of 52.81% year on year. The increase in performance is mainly due to a steady increase in sales revenue of blood purification equipment, a sharp increase in sales revenue of self-produced blood purification consumables, a decrease in fixed costs per unit of self-produced consumables, and an increase in gross margin.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.